An overview of the evidence and the current recommendations in terms of MHT's role in preventing cardiovascular disease will be discussed as well as its safety in women with pre-existing cardiovascular disease.
This lecture will clarify risk concepts in MHT, helping GPs understand and apply terms like absolute risk and hazard ratios in clinical decision-making.
In this Product Explainer, Sexual Health Physician Dr Terri Foran explains estradiol and progesterone combined hormone therapy, the first and only body-identical combined treatment for post-menopausal women (6 mins).
No longer is it okay to just monitor a patient with mild hyperparathyroidism as research shows the untreated condition is associated with a significantly increased risk of cardiovascular death
Tune in for "Gallbladder – When surgery is or is not needed" lecture
Tuesday 26th May, 7pm - 9pm AEST
Speaker
Dr David Yeo
Specialist Upper GI, Hepatobiliary and Bariatric Surgeon; Chris O’Brien Lifehouse, RPA and St George Hospitals
In this talk, surgeon, Dr David Yeo will answer these and many other real-world questions related to this common condition and provide an update on the latest recommendations for the assessment, investigation and management of gallbladder disease.